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In studies on the effects of environmental
factors on fetal growth, birth weight is usu-
ally corrected for gestational age. With the
generalized use of ultrasound examinations
in many countries, gestational age is often
defined or corrected from the ultrasound
measurements performed during or imme-
diately after the first trimester of pregnancy,
which are compared to a reference growth
curve. As an illustration, in a cohort study
investigating the association between expo-
sure to perfluorinated chemicals and fetal
growth, Fei et al. (2007) defined gestational
age from ultrasound measures performed
before 24 gestational weeks and, if this
information was missing, from the date of
the last menstrual period (LMP). 
The superiority of ultrasound measure-
ments over other approaches to predict the
date of delivery (Lynch and Zhang 2007)
does not imply that ultrasound-based gesta-
tional age leads to an unbiased estimate of
the effect of environmental factors on fetal
growth. The use of ultrasound-based gesta-
tional age assumes that fetal ultrasound
measurements at a given gestational week
during the first trimester have very little vari-
ability. However, there is some evidence to
the contrary (Bukowski et al. 2007). Part of
this variability might be due to exposure to
environmental pollutants. If the environ-
mental pollutant considered can restrict fetal
growth as early as the first trimester, correct-
ing gestational age using first-trimester ultra-
sound measurements will erroneously
shorten the gestational age of these small-for-
gestational-age fetuses. This may lead to
underestimating effects of environmental
pollutants on birth weight or size controlled
for gestational age (Figure 1), compared with
studies using an accurately estimated date of
conception. In practice, an accurate estimate
of conception date may seldom be available
outside the setting of in vitro fertilization. An
alternative is reliance on LMP-based esti-
mates, which are prone to errors due to bad
recall, variability in the duration of the follic-
ular phase of the cycle and midcycle, and
early pregnancy bleeding (Lynch and Zhang
2007). Moreover, using the LMP-based esti-
mate of gestational age would be problematic
if, as already reported for specific environ-
mental pollutants (Windham et al. 2003),
the environmental factors considered could
influence the duration of the menstrual
cycle. Therefore, detailed studies may be
needed to determine the balance between the
possible biases in the estimated effect of the
environmental factor entailed by the use of
ultrasound-based measurements and LMP-
based estimates.
This potential bias has been recognized
by Savitz et al. (2002) and was alluded to
by Fei et al. (2007) in their “Discussion.”
However, its consequences have probably
not been fully acknowledged. When possi-
ble, researchers should conduct sensitivity
analyses using different measures of gesta-
tional age to help quantify the potential for
bias. The same approach could also be used
when gestational duration is the studied
outcome (Lynch and Zhang 2007).
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As described by Slama et al., it is not a sim-
ple matter to adjust for gestational age
when analyzing birth weights. Any estimate
of gestational age is prone to misclassifica-
tion, whether it is based on ultrasound or
last menstrual period (LMP). Ultrasound
measures are based on the assumption of
uniform early fetal growth or at least that
the exposure under study has no impact on
early fetal growth. This assumption is prob-
ably not always correct, as first demon-
strated by Henriksen et al. (1995). LMP
estimates are prone to large random mea-
surement errors that may become non-
random if the exposures under study affects
menstrual bleeding patterns. 
Although these problems are part of
textbook knowledge (Olsen and Basso
2007), their impact appears to be limited in
our experience. In our study (Fei et al.
2007), the analyses based primarily on LMP
estimates provided a regression coefficient of
–10.35 [95% confidential interval (CI),
–20.6 to –0.15] between perfluorooctanoate
and birth weight, compared with the regres-
sion coefficient of –10.63 (95% CI, –20.79
to –0.47) we presented in the article after
adjustment for ultrasound-based gestational
age. The reason is probably that large ran-
dom errors of gestational age affect estimates
much more than smaller systematic errors.
Furthermore, perfluorinated chemicals may
not impair early fetal growth.
Birth weight is a function of fetal
growth and the duration of the pregnancy,
but until better estimates become available,
we must use these imprecise measures of
gestational age to determine the duration of
pregnancy. If the exposure under study
slows early fetal growth, adjustment for ges-
tational age based on ultrasound may
underestimate an effect of the exposure on
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Figure 1. Hypothetical evolution of a fetal meas-
urement (e.g., fetal length) during pregnancy for a
pregnancy exposed or unexposed to an environ-
mental factor that can affect fetal growth from
early pregnancy. The ultrasound examination
leads the obstetrician to correct the date of con-
ception (t0) for the exposed pregnancy by Δt, so
this exposed pregnancy is not compared with
unexposed pregnancies with the same gestational
age D (solid curve) as it should, but instead with
gestational age D – Dt (dashed blue curve).
Consequently, the estimated difference in the ges-
tational age–specific fetal measurement at birth
between exposed and unexposed pregnancies is
not the correct value β but a smaller value β´.fetal growth and overestimate a risk of
preterm birth. A similar bias is expected when
the results are adjusted for gestational age
based on LMP data if the exposure prolongs
menstrual cycles. 
We thank Slama et al. for reminding us
that estimating gestational age is always a
problem. 
The authors declare they have no competing
financial interests.
Jørn Olsen
Chunyuan Fei
Department of Epidemiology
University of California, Los Angeles
Los Angeles, California 
E-mail: jo@ucla.edu
REFERENCES
Fei C, McLaughlin JK, Tarone RE, Olsen J. 2007. Perfluorinated
chemicals and fetal growth: a study within the Danish
National Birth Cohort. Environ Health Perspect
115:1677–1682.
Henriksen TB, Wilcox AJ, Hedegaard M, Secher NJ. 1995.
Bias in studies of preterm and postterm delivery due to
ultrasound assessment of gestational age. Epidemiology
6:533–537.
Olsen J, Basso O. 2005. Reproductive epidemiology. In:
Handbook of Epidemiology (Ahrens W, Pigeot I, eds).
Berlin:Springer, 1043–1109.
Reassessing the Risks of
Tamiflu Use during a Pandemic
to the Lower Colorado River
doi:10.1289/ehp.11407
We wish to highlight an error in the article
“Potential Risks Associated with the
Proposed Widespread Use of Tamiflu”
(Singer et al. 2007) in which we predicted
environmental concentrations of Tamiflu
(influenza antiviral) in several catchments in
the United States and the United Kingdom.
An incorrect assumption was made in the
hydrology of one of these catchments, the
Lower Colorado River (LC).
In that study (Singer et al. 2007), we
used flow data generated by the U.S.
Geological Survey (USGS) and presented in
BASINS [U.S. Environmental Protection
Agency (EPA) 2001], as well as watershed
population statistics summarized by
Anderson et al. (2004). We (Singer et al.
2007) presented the flow of the LC as
1,223,424 m3/day, serving a population of
5,861,200, thereby providing 0.2 m3/per-
son/day of available dilution. These values
were used to determine the predicted
environmental concentration of oseltamivir
carboxylate (OC), the active antiviral
metabolite of the prodrug oseltamivir phos-
phate (Tamiflu), in the river during an
influenza pandemic. 
Unlike the other rivers investigated in the
study, the mouth of the LC is in Mexico.
Owing to its legal requirement as per Article
15 of the U.S.–Mexican Water Treaty (U.S.
Government 1944), the United States
releases 1,850,234,000 m3/year of the
Colorado River to Mexico (Matuska 2007;
U.S. Government 1944). This flow equates
to 5,069,134 m3/day, which is roughly
5-fold higher than the values used in our pre-
vious study (Singer et al. 2007). Hence, the
predicted environmental concentration of
OC in the LC was considerably over-
estimated. 
Detailed characterization of pollution
risks in the LC is particularly challenging
because of a) the arid environment and high
evaporation; b) water conservation efforts
lending many rivers to run dry; and
c) numerous diversions for irrigation and
domestic use. A survey of the rivers that join
the LC indicate few, if any, significant
inflows into the LC from major metropoli-
tan areas downstream of Las Vegas (USGS
2008). Notably, the only other major city
that might feed into the LC is Phoenix,
which discharges into the Gila River. The
daily mean discharge of the Gila River where
it joins the LC is 464.8 m3/day (in 2007),
thereby augmenting the LC flow by < 10%
(USGS 2008). Hence, risk characterization
of this catchment was focused on the sewage
discharge from Las Vegas to the LC.
Las Vegas lies within Clark County,
Nevada, and has a population of 1,996,542
(Clark County Department of Comprehen-
sive Planning 2007). Wastewater treatment
plants from Clark County produce approxi-
mately 757,000 m3/day, which is consistent
with a population of 2,102,777, assuming
360 L/person/day, as is consistent for U.S.
water usage patterns [Water Services
Regulation Authority (OFWAT) 2007].
The wastewater is discharged into the Las
Vegas Wash, a reach of Boulder Basin con-
taining Lake Mead; Lake Mead has a storage
capability of 17,500,000,000 m3 of water
(Matuska 2007).
In the event of an influenza pandemic
with a clinical infection rate of 35%, and
assuming 100% pharmaceutical coverage of
the infected population, approximately
3.0 ng OC would accumulate in each liter of
water in Lake Mead. Expectations are such
that only 25% of the infected population
will receive Tamiflu (U.S. Department of
Health and Human Services 2006), resulting
in < 1 ng/L in Lake Mead. Given the average
3.9-year retention time within Lake Mead
(LaBounty and Burns 2005; LaBounty and
Horn 1997), the OC concentrations will
accumulate (OC is poorly biodegradable) in
the lake over the course of a pandemic—
unlike in rivers, which were previously mod-
elled (Singer et al. 2007). Hence, risk
characterization of the LC indicates that the
predicted environmental concentration of
OC will be well below levels known to
induce viral resistance (Aoki et al. 2007;
Hurt et al. 2007).
One remaining concern is the poor mix-
ing and highly stratified nature of Lake
Mead; for example, the wastewater input
into the lake is often slow to mix completely
with the rest of the water column (LaBounty
and Horn 1997), resulting in 40-times
greater perchlorate levels in the themocline
(30–40 m depth), than in the epilimnion or
hypolimnion (LaBounty and Burns 2005).
Such observations can be used to predict
that OC concentrations > 80 ng/L may be
expected in the thermocline in a pandemic
situation. However, because wastewater
comprises only 1.5% of Lake Mead’s flow
and because the water in Lake Mead is dis-
charged through the Hoover Dam from the
hypolimnion, the location of lowest pollu-
tion, there is a low risk to the environment
as a consequence of OC release.
Although we are pleased that the risk to
the LC is lower than originally reported, this
reinterpretation does not change the overall
thrust of the article (Singer et al. 2007):
After an influenza pandemic, OC concen-
trations in rivers would be considerably
greater than previously seen for any other
pharmaceutical, with the actual impact vary-
ing based on dilution within a catchment.
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Incidence of New Onset
Asthma after the World Trade
Center Disaster
doi:10.1289/ehp.11331
Wheeler et al. (2007) provided useful infor-
mation on the well-recognized problem of
airways disease resulting from World Trade
Center (WTC) exposure, reporting a 3-year
risk of 3.6% for new physician-diagnosed
asthma. As a pulmonologist in New York
City who has also treated many WTC
workers in a dedicated program, I would
like to share the perspectives that my clini-
cian colleagues have shared with me. 
The diagnosis of asthma, even if made
by physicians, is often nonspecific and based
on symptoms that are nonspecific, as well as
common. Diagnostic clues such as chronic-
ity, recurrence, response to therapy, and
variability in pulmonary function are not
available on the first visit or the first few vis-
its. A diagnosis bias toward asthma may
operate for many reasons: a) a group under
surveillance has an increased awareness of
the target disease; b) asthma has been widely
publicized to physicians, as well as to the
public, as a result of WTC exposure; c) lists
of accepted diagnoses required on first visits
by monitoring and treatment programs,
insurance companies, and compensation sys-
tems may guide the physician’s diagnosis to
asthma even if he/she is not certain that this
diagnosis has been established; and d) bias
may exist in specifying the start of an on-
going illness, so that patients tend to associ-
ate it with a remarkable event like the WTC
disaster even if symptoms or a physician’s
diagnosis preceded this event. Wheeler et al.
(2007) recognized the difficulty of estimat-
ing the incidence of disease, given the
propensity of patients to cite a diagnosis that
may not have been substantiated and to pre-
sent for care only if symptomatic. 
Wheeler et al. (2007) noted that even if
all exposed persons were included in the
denominator, the incidence of new asthma
was still high. Much weight is placed on the
estimated incidence of new asthma in the
general population, for which the authors
cited a review article, which in turn, cited a
study from rural Minnesota that ended
25 years ago (Yungingen et al. 1992).
Incidence of asthma is affected by region
(including rural vs. inner city), occupation,
smoking, temporality, and other factors.
Wheeler et al. (2007) have brought
their information to public attention to be
confirmed by more specific criteria for diag-
nosis, longer clinical follow-up, and addi-
tional estimates of incidence in relevant
urban populations.
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Urinary Mercury Levels
in Children with
Amalgam Fillings 
doi:10.1289/ehp.11235
Woods et al. (2007) reported on exposure
to dental amalgam fillings and urinary mer-
cury excretion in children. They stated that
“urinary mercury concentrations are widely
used as a measure of mercury exposure from
dental amalgam fillings.” We would like to
point out some caveats about interpreting
the results of mercury in urine. 
Clarkson and Magos (2006) and others
(Mutter et al. 2007; Nilsson and Nilsson
1986; Nuttal 2004) noted that urinary mer-
cury is a rough indicator of mercury from
dental amalgams. In fact, the urinary mer-
cury concentration is unlikely to be a robust
biological indicator for prolonged exposure
to mercury vapor from dental amalgam.
Previous postmortem studies in humans
have shown that mercury levels originating
from dental amalgam surfaces and retained
in tissues are higher in brain regions and
thyroid than those measured in renal cortex
(Guzzi et al. 2006). 
These findings are consistent with the
fact that kidneys are the major contributors
of urinary mercury (Magos and Clarkson
2006; Nuttal 2004), and the concentrations
of mercury in urine may not reflect the tis-
sue retention of mercury in more sensitive
tissues such as brain and endocrine glands.
This might explain the association between
an increased frequency and severity of clini-
cal symptoms among individuals with den-
tal amalgams and consistently reduced
levels of excretion of total mercury in urine
(Minoia et al. 2006; Nilsson and Nilsson
1986). 
In addition, Woods et al. (2007) listed
several factors that may be involved in the
differences in urinary mercury concentra-
tions between the sexes. However, they did
not mention bruxism in the text. Bruxism
has an important causative role in the
increased concentration of mercury in urine
(Barregard et al. 1995). Because various
reports have suggested that bruxing behav-
ior may increase the urinary levels of mer-
cury (Isacsson et al. 1997), Woods et al.
should have included it as a potential con-
founder factor. 
As a result of their randomized trials,
Woods et al. (2007) evaluated the influence
of sex on mercury excretion rates. They
found that girls have a more significant
increase in the rate of mercury excreted in
urine than boys. Thus, this association
might confer a lower mercury toxicity risks
in girls. 
Our experience regarding the care and
treatment of adverse mercury amalgam
events among adult individuals does not
support the hypothesis that males might be
more susceptible than females to the adverse
events caused by long-term exposure to mer-
cury vapor from amalgams (Guzzi et al.
2005). Our findings, which were derived
from an ongoing study regarding clinically
significant adverse events occurred in 289
adults patients due to mercury amalgam fill-
ings, showed that females are two to three
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Correspondencetimes more likely to develop local (e.g.,
lichenoid contact stomatitis) or systemic
adverse health outcomes (e.g., skin disor-
ders) compared with males [217 of 289 were
women (75.09%) with a median age of 43;
72 of 289 were men (24.91%) with a
median age of 40.5; female to male ratio,
3.1:1]. Therefore, in our experience, adult
females were more likely to be affected by
prolonged exposure to mercury vapor
released from dental amalgams. 
Moreover, given that inorganic mercury
[Hg2+] binds mainly to thiol ligands [–SH]
as homocysteine (Bridges and Zalups 2004),
we suggest that future clinical trials address-
ing the role of sex in mercury excretion
should include an evaluation of serum
homocysteine, which is higher in males than
in females and might account for an
increased tissue retention of mercury
(Novembrino et al. 2006). 
Finally, Woods et al. (2007) did not con-
sider the importance of determining whether
the exposure to mercury vapor emitted from
amalgams may affect the immune system of
children (Pigatto and Meroni 2006). Indeed,
mercury-induced immunotoxicity arises far
earlier than overt toxicity in the renal and
central nervous systems. 
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